Sunday, July 24, 2016 9:34:55 AM
Here's how I see the issue. Most of Cellceutix's problem with investors dissatisfaction and even funding more trials revolves around the current depressed share price.
I have been searching around for ways that Cellceutix's management can artificially inflate their share price so they can keep current investors happy and fund more trials with less dilution.
I believe I may have stumbled across a perfect solution.
Cellceutix just needs to sign up for a major healthcare conference and submit a "misleading" title for their upcoming presentation. Think of the advantages of this technique. Investors will glob onto the title, especially if they make it something dramatic it will be spread around the message boards like its actually a valid expectation. Now here is the real trick. Just prior to the presentation management can rename the presentation to a realistic title. I like this technique because I'm pretty sure it's not illegal even though it could be considered intentionally "misguiding" investors.
I have seen this technique used effectively by other companies. Hey as long as the stock price is increasing no one will mind will they?
LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM